Inhibition effect of tacrolimus and platelet-derived growth factor-BB on restenosis after vascular intimal injury
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference39 articles.
1. The importance of patency in patients with critical limb ischemia undergoing endovascular revascularization for infrapopliteal arterial disease;Baumann;Front Cardiovasc. Med.,2014
2. Comparative effectiveness of peripheral vascular intervention versus surgical bypass for critical limb ischemia in the Vascular Study Group of Greater New York;Meltzer;J Vasc Surg,2016
3. Influence of repeat intervention on the risk of major amputation after infrapopliteal angioplasty for critical limb ischemia;Utsunomiya;J. Endovasc. Ther.,2016
4. The mid-Term clinical follow-Up using drug-Eluting balloons on tibial artery de novo lesions in patients with critical limb ischemia: a cohort study;Tolva;Vasc. Endovascular Surg.,2016
5. Drug-eluting stents remain the golden standard for below-the-knee occlusive disease;Mosquera Arochena;J. Cardiovasc. Surg. (Torino),2016
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pharmacological prevention of intimal hyperplasia: A state-of-the-art review;Pharmacology & Therapeutics;2022-07
2. Tacrolimus inhibits oral carcinogenesis through cell cycle control;Biomedicine & Pharmacotherapy;2021-07
3. Jujuboside B Inhibits Neointimal Hyperplasia and Prevents Vascular Smooth Muscle Cell Dedifferentiation, Proliferation, and Migration via Activation of AMPK/PPAR-γ Signaling;Frontiers in Pharmacology;2021-06-24
4. Nucleolin promotes Ang�II‑induced phenotypic transformation of vascular smooth muscle cells via interaction with tropoelastin mRNA;International Journal of Molecular Medicine;2019-02-04
5. Exogenous SERP1 attenuates restenosis by restoring GLP-1 receptor activity in diabetic rats following vascular injury;Biomedicine & Pharmacotherapy;2018-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3